Mutual of America Capital Management LLC Lowers Stock Holdings in Progyny, Inc. (NASDAQ:PGNY)

Mutual of America Capital Management LLC lessened its holdings in shares of Progyny, Inc. (NASDAQ:PGNY) by 4.5% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 47,432 shares of the company’s stock after selling 2,249 shares during the quarter. Mutual of America Capital Management LLC’s holdings in Progyny were worth $1,357,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in PGNY. Caprock Group LLC raised its stake in shares of Progyny by 5.3% in the first quarter. Caprock Group LLC now owns 6,288 shares of the company’s stock valued at $240,000 after acquiring an additional 319 shares in the last quarter. RiverPark Advisors LLC grew its position in shares of Progyny by 9.6% during the second quarter. RiverPark Advisors LLC now owns 5,408 shares of the company’s stock worth $155,000 after buying an additional 474 shares in the last quarter. State of Michigan Retirement System increased its stake in shares of Progyny by 2.5% during the first quarter. State of Michigan Retirement System now owns 20,479 shares of the company’s stock worth $781,000 after buying an additional 500 shares during the period. Allspring Global Investments Holdings LLC raised its holdings in Progyny by 9.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 6,260 shares of the company’s stock valued at $239,000 after acquiring an additional 543 shares in the last quarter. Finally, Arizona State Retirement System lifted its stake in Progyny by 2.6% in the second quarter. Arizona State Retirement System now owns 24,313 shares of the company’s stock worth $696,000 after acquiring an additional 609 shares during the last quarter. Hedge funds and other institutional investors own 94.93% of the company’s stock.

Insider Transactions at Progyny

In related news, President Michael E. Sturmer sold 9,030 shares of the firm’s stock in a transaction dated Tuesday, July 16th. The shares were sold at an average price of $30.00, for a total value of $270,900.00. Following the completion of the sale, the president now owns 362,583 shares in the company, valued at $10,877,490. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 12.30% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. JMP Securities lowered shares of Progyny from an “outperform” rating to a “market perform” rating in a report on Thursday, September 19th. Canaccord Genuity Group downgraded Progyny from a “buy” rating to a “hold” rating and decreased their price target for the stock from $37.00 to $24.00 in a report on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price objective on Progyny from $31.00 to $22.00 and set an “overweight” rating on the stock in a report on Thursday, September 19th. Leerink Partnrs cut Progyny from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Finally, Jefferies Financial Group dropped their price target on shares of Progyny from $31.00 to $24.00 and set a “buy” rating on the stock in a research note on Thursday, September 19th. Seven research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $27.73.

Progyny Stock Performance

PGNY stock opened at $16.72 on Friday. The stock has a market capitalization of $1.51 billion, a PE ratio of 27.41, a price-to-earnings-growth ratio of 1.62 and a beta of 1.45. The company has a fifty day moving average of $23.10 and a 200-day moving average of $28.16. Progyny, Inc. has a one year low of $13.93 and a one year high of $42.08.

Progyny (NASDAQ:PGNY) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.17 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.17. The company had revenue of $304.09 million for the quarter, compared to analyst estimates of $305.32 million. Progyny had a return on equity of 11.97% and a net margin of 5.54%. The firm’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.15 EPS. Equities analysts forecast that Progyny, Inc. will post 0.64 earnings per share for the current fiscal year.

Progyny Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.